A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions (Q59349181)
Jump to navigation
Jump to search
scientific article published on 01 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions |
scientific article published on 01 March 2011 |
Statements
A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial (English)
Seung-Whan Lee
Seong-Wook Park
Young-Hak Kim
Sung-Cheol Yun
Duk-Woo Park
Cheol Whan Lee
Soo-Jin Kang
Seung-Jung Park
Jae-Hwan Lee
Si Wan Choi
Nae-Hee Lee
Yoon Haeng Cho
Won-Yong Shin
Seung-Jin Lee
Se-Whan Lee
Min-Su Hyon
Duk-Won Bang
Young-Jin Choi
Hyun-Sook Kim
Bong-Ki Lee
Keun Lee
Hoon-Ki Park
Chang-Bum Park
Sang-Gon Lee
Min-Kyu Kim
Kyoung-Ha Park
Woo-Jung Park
DECLARE-LONG II Study Investigators